1 Min Read
Aug 25 (Reuters) - ONCOLOGY VENTURE SWEDEN AB
* Q2 PRETAX LOSS SEK 10.6 MILLION VERSUS LOSS SEK 5.2 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.